Interested parties can join the conference call by dialing 877-407-0989 for toll-free access or 201-389-0921 for international participants, ten minutes before the scheduled start. A live webcast and subsequent replay will also be accessible through the company's investor relations website at www.amphastar.com.
Amphastar Pharmaceuticals Sets August 6 Date for Q2 Results
Amphastar Pharmaceuticals, Inc. will report its financial performance for the second quarter of 2026 on August 6, following the close of the market. The Rancho Cucamonga-based biopharmaceutical company plans to host a conference call at 2:00 p.m. Pacific Time to discuss the results with investors and analysts.
Amphastar focuses on the development and manufacturing of complex generic and proprietary injectable, inhalation, and intranasal products. The company’s portfolio includes notable brands such as BAQSIMI, Primatene MIST, and Cortrosyn, which are distributed primarily through group purchasing organizations and drug wholesalers.
Comments (0)
No comments yet. Be the first!